3D Printed Drugs Market by Dosage Form (Tablet, Capsule, Nanoparticles), Technology (Inkjet Printing, Zipdose, Direct Write, Stereolithography, Fused Deposition Modeling), Application (Orthopedic, Neurology, Dental) - Global Forecast to 2027
The global 3D Printed Drugs market is projected to reach USD 110 million by 2027 from ~USD 50 million in 2022, at a CAGR of 17% during the forecast period
To know about the assumptions considered for the study, Request for Free Sample Report
3D printed drugs have ability to form a definite 3D structure with a precise and unique dosages for individual patients to present more efficient drug administration. 3D printing tool allows small-scale production of medicines by using approach of 3D modeling software to build an object layer-by-layer for solid drugs. By adjusting the printing parameters, the dosages, drug combinations and flavors can be personalized. US Food and Drug Administration (US FDA) approved first 3D printed drug Spritam to treat epilepsy symptoms in 2015.
This Market is expected to witness lucrative growth during next five years. The growth of this market is driven by factors such as increasing adoption of personalized drugs, growing research and development activities, increasing disease prevalence, increasing availability of individual drugs and the production of combination medications. However, the usage of 3D printing to develop illegal drugs restrains the growth of the market.
The 3D printed drugs market is categorized on the basis of dosage form, technology, application and region. Based on dosage form, the 3D printed drugs market is segmented into tablets, capsules, multi drug implants, nanoparticles, solutions, and other dosage forms. At present, 3D printed drugs are available only in the form of tablets in the market. However, the other dosage forms are likely to be commercialized in the coming years. On the basis of technology, the 3D printed drugs market is segmented into inkjet printing, direct write, zip dose, thermal inkjet printing, fused deposition modeling, powder bed printing, stereolithography (SLA), and semi solid extrusion (SSE). On the basis of application, the 3D printed drugs market is segmented into neurology, orthopedic, dental and other applications segments. Based on the region, the market is divided into North America, Europe, Asia Pacific and Rest of World region.
To know about the assumptions considered for the study, download the pdf brochure
The report is a comprehensive study of current market trends, industry growth drivers, restraints, opportunities and challenges. The exhaustive regional and country level 3D printed drugs market analysis is provided for 2020-2027. Each market is comprehensively analysed at a granular level to provide in-depth information.
The 3D printed drugs market is dominated by a few globally established players such as Aprecia Pharmaceuticals LLC (US), Bioduro (US), Acrux (US), AstraZeneca (UK), Biomedical modeling Inc. (US), GlaxoSmithKline Plc (UK), Merck KGaA (Germany), Cycle Pharmaceuticals (UK), among others.
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
TABLE OF CONTENTS
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKET COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
2.1.2.1 Key industry insights
2.2 MARKET SIZE ESTIMATION
2.3 MARKET GROWTH RATE PROJECTIONS
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
2.5 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.2 RESTRAINTS
5.2.3 OPPORTUNITIES
5.2.4 CHALLENGES
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
5.4 PRICING ANALYSIS
5.5 VALUE CHAIN ANALYSIS
5.6 ECOSYSTEM ANALYSIS
5.7 PATENT ANALYSIS
5.8 KEY CONFERENCES AND EVENTS IN 2022-2023
5.9 REGULATORY ANALYSIS
5.10 PORTER’S FIVE FORCES ANALYSIS
5.11 KEY STAKEHOLDER AND BUYING CRITERIA
6 3D PRINTED DRUGS MARKET, BY DOSAGE FORM, 2020-2027 (USD MILLION)
6.1 INTRODUCTION
6.2 TABLET
6.3 CAPSULE
6.4 MULTIDRUG IMPLANT
6.5 NANOPARTICLES
6.6 SOLUTIONS
6.7 OTHER PRODUCTS (IF ANY)
7 3D PRINTED DRUGS MARKET, BY TECHNOLOGY, 2020-2027 (USD MILLION)
7.1 INTRODUCTION
7.2 INKJET PRINTING
7.3 DIRECT WRITE
7.4 ZIP DOSE
7.5 THERMAL INKJET PRINTING
7.6 FUSED DEPOSITION MODELLING
7.7 POWDER BED PRINTING
7.8 STEREOLITHOGRAPHY (SLA)
7.9 SEMI SOLID EXTRUSION (SSE)
8 3D PRINTED DRUGS MARKET, BY APPLICATION, 2020-2027 (USD MILLION)
8.1 INTRODUCTION
8.2 ORTHOPEDIC
8.3 NEUROLOGY
8.4 DENTAL
8.5 OTHERS (IF ANY)
9 3D PRINTED DRUGS MARKET, BY REGION, 2020-2027 (USD MILLION)
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 US
9.2.2 CANADA
9.3 EUROPE
9.3.1 GERMANY
9.3.2 FRANCE
9.3.3 UK
9.3.4 ITALY
9.3.5 SPAIN
9.3.6 ROE
9.4 ASIA PACIFIC
9.4.1 JAPAN
9.4.2 CHINA
9.4.3 INDIA
9.4.4 REST OF APAC
9.5 REST OF THE WORLD (ROW)
9.5.1 LATIN AMERICA
9.5.2 MIDDLE EAST & AFRICA
10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 KEY PLAYER STRATEGIES
10.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
10.4 MARKET SHARE ANALYSIS, 2021
10.5 COMPANY EVALUATION QUADRANT
10.6 COMPANY EVALUATION QUADRANT – SME/START-UPS
10.7 COMPANY GEOGRAPHIC FOOTPRINT
10.8 COMPETITIVE SCENARIO
11 COMPANY PROFILES
11.1 APRECIA PHARMACEUTICALS, LLC
11.2 FABRX LTD
11.3 CYCLE PHARMACEUTICALS
11.4 GLAXOSMITHKLINE PLC.
11.5 ASTRAZENECA
11.6 TVASTA
11.7 MERCK KGGA
11.8 TERUMO CORPORATION
11.9 EXTEND BIOSCIENCES
11.1 BIODURO
11.11 AFFINITY THERAPEUTICS
11.12 TVASTA
11.13 OSMOTICA PHARMACEUTICALS
* Company profiles of 25 players will be provided in this section. This section will include Business Overview, Products Offered, Recent Developments, MnM View. Kindly note that the financial analysis and MnM View might not be captured in case of unlisted companies.
12 APPENDIX
12.1 INSIGHTS FROM INDUSTRY EXPERTS
12.2 DISCUSSION GUIDE
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
12.5 AVAILABLE CUSTOMIZATIONS
12.6 RELATED REPORTS
12.7 AUTHOR DETAILS
Growth opportunities and latent adjacency in 3D Printed Drugs Market